None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy volunteers with full capacity for civil conduct and aged between 18 and 60 years; 2. Volunteers can keep good communication with researchers and comply with various requirements of clinical trials, and sign informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1. Abnormal laboratory test results during screening and determined by the researcher to be clinically significant; 2. Volunteers who cannot tolerate venipunctures and have a history of needle sickness or blood sickness; 3, HBsAg positive, HCV-AB positive, HIV-AB positive or TP-AB positive; 4. Donate blood >= 500 mL within 4 weeks before screening, or have severe blood loss of at least 500 mL, or received blood transfusion within 8 weeks; 5. Used any prescription drugs, including common drugs such as antibiotics and Chinese herbal medicines within 4 weeks prior to screening; used non-prescription drugs or food supplements, such as vitamin and calcium supplements, within 2 weeks except for paracetamol Max. 1000 mg daily, ibuprofen Max. 2400 mg daily and local over-the-counter topical preparations; 6. Participated in clinical trials of any drugs or medical devices within 3 months prior to screening; 7. Volunteers who have any factors that the investigator considers inappropriate for participating in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma; | — |
Countries
China
Contacts
Peking University Third Hospital